Education
About Us
Working with TipRanks
Follow Us
Aroa Biosurgery Ltd (AU:ARX)
ASX:ARX
RESEARCH TOOLSreports
Total Valuation
Aroa Biosurgery Ltd has a market cap or net worth of AU$146.58M. The enterprise value is AU$179.06M.
Market CapAU$146.58M
Enterprise ValueAU$179.06M
Share Statistics
Aroa Biosurgery Ltd has 344.90M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding344.90M
Owned by Insiders0.42%
Owned by Instutions
Financial Efficiency
Aroa Biosurgery Ltd’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Aroa Biosurgery Ltd is ―. Aroa Biosurgery Ltd’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Aroa Biosurgery Ltd had revenue of AU$78.46M and earned -AU$12.72M in profits. Earnings per share was -AU$0.05.
RevenueAU$78.46M
Gross ProfitAU$66.80M
Operating Income-AU$13.38M
Pretax Income-AU$12.47M
Net Income-AU$12.72M
EBITDA-9.06M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -AU$10.11M and capital expenditures -AU$5.23M, giving a free cash flow of -AU$14.04M billion.
Operating Cash Flow-AU$10.11M
Free Cash Flow-AU$14.04M
Free Cash Flow per Share-AU$0.04
Dividends & Yields
Aroa Biosurgery Ltd pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.26
52-Week Price Change-20.00%
50-Day Moving Average0.49
200-Day Moving Average0.58
Relative Strength Index (RSI)39.25
Average Volume (3m)431.49K
Important Dates
Aroa Biosurgery Ltd upcoming earnings date is Nov 25, 2024, TBA.
Last Earnings DateMay 20, 2024
Next Earnings DateNov 25, 2024
Ex-Dividend Date―
Financial Position
Aroa Biosurgery Ltd as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Aroa Biosurgery Ltd has paid AU$250.67K in taxes.
Income TaxAU$250.67K
Effective Tax Rate―
Enterprise Valuation
Aroa Biosurgery Ltd EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Aroa Biosurgery Ltd has AU$27.73M in cash and marketable securities with AU$6.82M in debt, giving a net cash position of -AU$20.91M billion.
Cash & Marketable SecuritiesAU$27.73M
Total DebtAU$6.82M
Net Cash-AU$20.91M
Net Cash Per Share-AU$0.06
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Aroa Biosurgery Ltd is AU$0.84, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.84
Price Target Upside100.00%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast15.90%
EPS Growth Forecast8.52%